Calcitonin-Salmon

Calcitonin-salmon copies the salmon hormone rather than the human form because it is more potent and longer-lasting. Brands have included Miacalcin and Fortical; generic nasal spray is also described. The medicine has decades of use and FDA approval.

Calcitonin receptors on osteoclasts reduce bone breakdown and calcium release. Increased urinary calcium excretion also contributes to calcium lowering. These actions can modestly protect bone while lowering elevated blood calcium.

Uses include postmenopausal osteoporosis in women more than five years past menopause who cannot use other treatments; Paget disease, where excessive turnover weakens/deforms bone; and rapid lowering of dangerous hypercalcemia.

Nasal spray is used for postmenopausal osteoporosis as one spray into one nostril daily, alternating nostrils. Subcutaneous or intramuscular injection is used for Paget disease and hypercalcemia, and sometimes osteoporosis when spray is unsuitable. The injection’s rapid calcium effect is useful in hypercalcemia; patients requiring long-term injections may receive supervised home-administration training. Route and regimen depend on the actual product and indication.

The five-year placebo-controlled PROOF trial included 1,255 postmenopausal women. A daily 200 IU nasal dose reduced new spinal-fracture risk by approximately 33% versus placebo. Although statistically significant, the benefit was modest, and higher/lower tested doses did not show the same clear result. That uneven dose-response leaves uncertainty about robustness and does not justify routine escalation.

A2013European regulatory reassessment, echoed by an FDA advisory committee, pooled trial data and found a small but consistent increase in malignancy rates with prolonged calcitonin exposure. Regulators concluded that the modest benefit did not clearly outweigh risk for routine long-term osteoporosis treatment, narrowing the nasal spray’s role.

It is generally reserved for patients unable to use better-established bone treatments. Common effects include nasal irritation with spray and nausea/flushing with injections. The injection label also warns of severe allergic reactions and hypocalcemia.